O'Leary T J
Department of Cellular Pathology, Armed Forces Institute of Pathology, Washington, District of Columbia 20306-6000, USA.
Appl Immunohistochem Mol Morphol. 2001 Mar;9(1):3-8.
Over the last few years, the role of immunohistochemical analysis has been changing from that of an ancillary diagnostic technique to that of a stand-alone diagnostic method, the results of which determine treatment approach. With this change comes a need for increasing standardization of both preanalytical and analytical methods, so that results emanating from different laboratories are directly comparable. These efforts have been aided to some degree by the development of automated staining systems and by the increased use of test kits, but interlaboratory reproducibility for immunohistochemical methods is still far lower than that of most clinical analytical measurements. In this article, the author presents some approaches to further reduce intra- and interlaboratory variation in the performance of immunohistochemical assays, focusing attention on guidelines recently published by NCCLS.
在过去几年中,免疫组化分析的作用已从辅助诊断技术转变为独立的诊断方法,其结果决定治疗方案。随着这一转变,对分析前和分析方法标准化的需求日益增加,以便不同实验室得出的结果能够直接比较。自动染色系统的发展以及检测试剂盒使用的增加在一定程度上推动了这些努力,但免疫组化方法的实验室间可重复性仍远低于大多数临床分析测量。在本文中,作者提出了一些进一步减少免疫组化检测中实验室内部和实验室间差异的方法,重点关注美国国家临床实验室标准委员会(NCCLS)最近发布的指南。